INNOSPEC INC., 10-Q filed on 09 Aug 23
v3.23.2
Cover Page - shares
6 Months Ended
Jun. 30, 2023
Aug. 01, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Document Quarterly Report true  
Document Transition Report false  
Current Fiscal Year End Date --12-31  
Document Period End Date Jun. 30, 2023  
Securities Act File Number 1-13879  
Entity Registrant Name INNOSPEC INC.  
Entity Central Index Key 0001054905  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 98-0181725  
City Area Code 303  
Entity Address, Postal Zip Code 80112  
Local Phone Number 792 5554  
Security Exchange Name NASDAQ  
Title of 12(b) Security Common stock  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   24,865,986
Entity Address, Address Line One 8310 South Valley Highway  
Entity Address, Address Line Two Suite 350  
Entity Address, City or Town Englewood  
Entity Address, State or Province CO  
Trading Symbol IOSP  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
v3.23.2
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Net sales $ 480.4 $ 467.6 $ 990.0 $ 940.0
Cost of goods sold (330.0) (327.8) (691.8) (660.9)
Gross profit 150.4 139.8 298.2 279.1
Operating expenses:        
Selling, general and administrative (105.6) (83.4) (201.8) (168.3)
Research and development (10.6) (10.1) (21.2) (20.2)
Total operating expenses (116.2) (93.5) (223.0) (188.5)
Operating income 34.2 46.3 75.2 90.6
Other income/(expense), net 2.7 (3.6) 6.4 0.7
Interest expense, net (0.3) (0.4) 0.0 (0.8)
Income before income tax expense 36.6 42.3 81.6 90.5
Income tax expense (7.7) (10.0) (19.5) (21.7)
Net income $ 28.9 $ 32.3 $ 62.1 $ 68.8
Earnings per share:        
Basic $ 1.16 $ 1.3 $ 2.5 $ 2.77
Diluted $ 1.16 $ 1.29 $ 2.48 $ 2.76
Weighted average shares outstanding (in thousands):        
Basic 24,868 24,805 24,835 24,798
Diluted 24,980 24,971 25,010 24,967
v3.23.2
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Statement of Comprehensive Income [Abstract]        
Net income $ 28.9 $ 32.3 $ 62.1 $ 68.8
Changes in cumulative translation adjustment, net of tax of $(0.3) million, $1.4 million, $(0.7) million and $1.2 million, respectively 1.4 (16.9) 6.1 (20.7)
Amortization of prior service cost, net of tax of $0.0 million, $(0.1) million, $0.0 million and $(0.1) million, respectively 0.1 0.1 0.2 0.2
Amortization of actuarial net losses/(gains), net of tax of $0.1 million, $0.0 million, $0.2 million and $0.0 million, respectively (0.4) 0.2 (0.8) 0.3
Total other comprehensive income/(loss) 1.1 (16.6) 5.5 (20.2)
Total comprehensive income $ 30.0 $ 15.7 $ 67.6 $ 48.6
v3.23.2
Condensed Consolidated Statements of Comprehensive Income (Parenthetical) (Unaudited) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Statement of Comprehensive Income [Abstract]        
Changes in cumulative translation adjustment, tax $ (0.3) $ 1.4 $ (0.7) $ 1.2
Amortization of prior service credit, tax 0.0 0.1 0.0 0.1
Amortization of actuarial net losses, tax $ 0.1 $ 0.0 $ 0.2 $ (0.0)
v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 165.9 $ 147.1
Trade and other accounts receivable (less allowances of $9.6 million and $7.7 million respectively) 310.9 334.6
Inventories (less allowances of $27.2 million and $27.1 million respectively):    
Finished goods 248.3 259.3
Raw materials 108.4 113.8
Total inventories 356.7 373.1
Prepaid expenses 10.5 14.1
Prepaid income taxes 9.8 3.3
Other current assets 0.7 0.4
Total current assets 854.5 872.6
Net property, plant and equipment 242.3 220.9
Operating lease right-of-use assets 45.9 45.3
Goodwill 360.6 358.8
Net book amount at June 30 46.7 45.0
Deferred tax assets 5.9 5.9
Pension asset 49.1 48.1
Other non-current assets 5.8 7.1
Total assets 1,610.8 1,603.7
Current liabilities:    
Accounts payable 157.9 165.3
Accrued liabilities 174.7 202.9
Current portion of operating lease liabilities 14.3 13.9
Current portion of plant closure provisions 4.3 5.3
Current portion of accrued income taxes 13.7 18.4
Total current liabilities 364.9 405.8
Operating lease liabilities, net of current portion 31.6 31.4
Plant closure provisions, net of current portion 52.6 51.9
Accrued income taxes, net of current portion 11.6 21.0
Unrecognized tax benefits 14.0 13.4
Deferred tax liabilities 27.3 26.2
Pension liabilities and post-employment benefits 12.4 12.2
Other non-current liabilities 1.6 1.4
Total liabilities 516.0 563.3
Equity:    
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares 0.3 0.3
Additional paid-in capital 356.7 354.1
Treasury stock (4,688,514 and 4,788,966 shares at cost, respectively) (94.2) (95.4)
Retained earnings 969.1 924.2
Accumulated other comprehensive loss (139.7) (145.2)
Total Innospec stockholders' equity 1,092.2 1,038.0
Non-controlling interest 2.6 2.4
Total equity 1,094.8 1,040.4
Total liabilities and equity $ 1,610.8 $ 1,603.7
v3.23.2
Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Allowances for doubtful accounts $ 9.6 $ 7.7
Inventory allowances $ 27.2 $ 27.1
Common stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 40,000,000 40,000,000
Common stock, shares issued 29,554,500 29,554,500
Treasury stock, shares 4,688,514 4,788,966
v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows from Operating Activities    
Net income $ 62.1 $ 68.8
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 19.2 20.8
Deferred taxes 1.1 1.0
Non-cash movements on defined benefit pension plans (1.7) (1.3)
Stock option compensation 3.9 3.2
Changes in assets and liabilities, net of effects of acquired and divested companies:    
Trade and other accounts receivable 26.4 (62.1)
Inventories 19.0 (88.3)
Prepaid expenses 3.8 6.5
Accounts payable and accrued liabilities (37.7) 20.9
Plant closure provisions (0.5) 0.0
Accrued income taxes (21.6) (4.2)
Unrecognized tax benefits 0.6 0.0
Other assets and liabilities 2.2 (1.8)
Net cash provided by/(used in) operating activities 76.8 (36.5)
Cash Flows from Investing Activities    
Capital expenditures (32.6) (17.4)
Internally developed software (6.7) 0.0
Net cash used in investing activities (39.3) (17.4)
Cash Flows from Financing Activities    
Non-controlling interest 0.2 0.0
Proceeds from revolving credit facility 0.0 0.0
Repayments of revolving credit facility 0.0 0.0
Repayments of finance leases 0.0 (0.1)
Refinancing costs (1.5) 0.0
Dividend paid (17.2) (15.6)
Issue of treasury stock 0.7 2.1
Repurchase of common stock (1.0) (2.7)
Net cash used in financing activities (18.8) (16.3)
Effect of foreign currency exchange rate changes on cash 0.1 (0.2)
Net change in cash and cash equivalents 18.8 (70.4)
Cash and cash equivalents at beginning of period 147.1 141.8
Cash and cash equivalents at end of period $ 165.9 $ 71.4
v3.23.2
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Non-Controlling Interest [Member]
Beginning Balance at Dec. 31, 2021 $ 1,033.0 $ 0.3 $ 346.7 $ (90.6) $ 822.9 $ (46.9) $ 0.6
Net income 68.8       68.8    
Dividend paid (15.6)       (15.6)    
Changes in cumulative translation adjustment, net of tax (20.7)         (20.7)  
Share of net income 0.1           0.1
Treasury stock reissued 2.0   1.0 1.0      
Treasury stock repurchased (2.7)     2.7      
Stock option compensation 3.2   3.2        
Amortization of prior service cost, net of tax 0.2         0.2  
Amortization of actuarial net losses, net of tax 0.3         0.3  
Ending Balance at Jun. 30, 2022 1,068.6 0.3 350.9 (92.3) 876.1 (67.1) 0.7
Beginning Balance at Mar. 31, 2022 1,068.9 0.3 349.6 (90.6) 859.4 (50.5) 0.7
Net income 32.3       32.3    
Dividend paid (15.6)       (15.6)    
Changes in cumulative translation adjustment, net of tax (16.9)         (16.9)  
Treasury stock reissued (0.1)   (0.2) 0.1      
Treasury stock repurchased (1.8)     1.8      
Stock option compensation 1.5   1.5        
Amortization of prior service cost, net of tax 0.1         0.1  
Amortization of actuarial net losses, net of tax 0.2         0.2  
Ending Balance at Jun. 30, 2022 1,068.6 0.3 350.9 (92.3) 876.1 (67.1) 0.7
Beginning Balance at Dec. 31, 2022 1,040.4 0.3 354.1 (95.4) 924.2 (145.2) 2.4
Net income 62.1       62.1    
Dividend paid (17.2)       (17.2)    
Changes in cumulative translation adjustment, net of tax 6.1         6.1  
Share of net income 0.2           0.2
Treasury stock reissued 0.8   (1.3) 2.1      
Treasury stock repurchased (0.9)     0.9      
Stock option compensation 3.9   3.9        
Amortization of prior service cost, net of tax 0.2         0.2  
Amortization of actuarial net losses, net of tax (0.8)         (0.8)  
Ending Balance at Jun. 30, 2023 1,094.8 0.3 356.7 (94.2) 969.1 (139.7) 2.6
Beginning Balance at Mar. 31, 2023 1,080.6 0.3 354.8 (93.5) 957.4 (140.8) 2.4
Net income 28.9       28.9    
Dividend paid (17.2)       (17.2)    
Changes in cumulative translation adjustment, net of tax 1.4         1.4  
Share of net income 0.2           0.2
Treasury stock reissued (0.1)   (0.1) 0.0      
Treasury stock repurchased (0.7)     0.7      
Stock option compensation 2.0   2.0        
Amortization of prior service cost, net of tax 0.1         0.1  
Amortization of actuarial net losses, net of tax (0.4)         (0.4)  
Ending Balance at Jun. 30, 2023 $ 1,094.8 $ 0.3 $ 356.7 $ (94.2) $ 969.1 $ (139.7) $ 2.6
v3.23.2
Condensed Consolidated Statements of Equity (Parenthetical) (Unaudited) - $ / shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Statement of Stockholders' Equity [Abstract]        
Dividend paid, per share $ 0.69 $ 0.63 $ 0.69 $ 0.63
v3.23.2
Insider Trading Arrangements
6 Months Ended
Jun. 30, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.23.2
Basis of Presentation
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation

NOTE 1 – BASIS OF PRESENTATION

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934. Accordingly, they do not include all the information and notes necessary for a comprehensive presentation of financial position, results of operations and cash flows.

It is our opinion, however, that all adjustments (consisting of normal, recurring adjustments, unless otherwise disclosed) have been made which are necessary for the condensed consolidated financial statements to be fairly stated. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed on February 22, 2023 (the “2022 Form 10-K”).

The results for the interim period covered by this report are not necessarily indicative of the results to be expected for the full year.

When we use the terms “Innospec,” “the Corporation,” “the Company,” “Registrant,” “the Group,” “we,” “us” and “our,” we are referring to Innospec Inc. and its consolidated subsidiaries unless otherwise indicated or the context otherwise requires.

v3.23.2
Segment Reporting
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Segment Reporting

NOTE 2 – SEGMENT REPORTING

The Company reports its financial performance based on three reportable segments, which are Performance Chemicals, Fuel Specialties and Oilfield Services.

The Company evaluates the performance of its segments based on operating income. The following table analyzes sales and other financial information by the Company’s reportable segments:

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

(in millions)

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Net Sales:

 

 

 

 

 

 

 

 

 

 

 

 

Personal Care

 

$

78.6

 

 

$

105.3

 

 

$

166.8

 

 

$

208.7

 

Home Care

 

 

19.7

 

 

 

25.3

 

 

 

43.4

 

 

 

49.7

 

Other

 

 

29.5

 

 

 

38.4

 

 

 

69.0

 

 

 

77.7

 

Performance Chemicals

 

 

127.8

 

 

 

169.0

 

 

 

279.2

 

 

 

336.1

 

Refinery and Performance

 

 

119.1

 

 

 

123.9

 

 

 

268.6

 

 

 

272.3

 

Other

 

 

35.1

 

 

 

52.5

 

 

 

75.9

 

 

 

95.9

 

Fuel Specialties

 

 

154.2

 

 

 

176.4

 

 

 

344.5

 

 

 

368.2

 

Oilfield Services

 

 

198.4

 

 

 

122.2

 

 

 

366.3

 

 

 

235.7

 

 

$

480.4

 

 

$

467.6

 

 

$

990.0

 

 

$

940.0

 

Operating income/(loss):

 

 

 

 

 

 

 

 

 

 

 

 

Performance Chemicals

 

$

9.2

 

 

$

28.8

 

 

$

19.6

 

 

$

54.1

 

Fuel Specialties

 

 

17.1

 

 

 

31.5

 

 

 

49.5

 

 

 

67.0

 

Oilfield Services

 

 

28.0

 

 

 

4.5

 

 

 

43.9

 

 

 

7.0

 

Corporate costs

 

 

(20.1

)

 

 

(18.5

)

 

 

(37.8

)

 

 

(37.5

)

Total operating income

 

$

34.2

 

 

$

46.3

 

 

$

75.2

 

 

$

90.6

 

v3.23.2
Earnings Per Share
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Earnings per Share

NOTE 3 – EARNINGS PER SHARE

Basic earnings per share is based on the weighted average number of common shares outstanding during the period. Diluted earnings per share includes the effect of options that are dilutive and outstanding during the period under the treasury stock method. Per share amounts are computed as follows:

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Numerator (in millions):

 

 

 

 

 

 

 

 

 

 

 

 

Net income available to common stockholders

 

$

28.9

 

 

$

32.3

 

 

$

62.1

 

 

$

68.8

 

Denominator (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

24,868

 

 

 

24,805

 

 

 

24,835

 

 

 

24,798

 

Dilutive effect of stock options and awards

 

 

112

 

 

 

166

 

 

 

175

 

 

 

169

 

Denominator for diluted earnings per share

 

 

24,980

 

 

 

24,971

 

 

 

25,010

 

 

 

24,967

 

Net income per share, basic:

 

$

1.16

 

 

$

1.30

 

 

$

2.50

 

 

$

2.77

 

Net income per share, diluted:

 

$

1.16

 

 

$

1.29

 

 

$

2.48

 

 

$

2.76

 

 

In the three and six months ended June 30, 2023, the average number of anti-dilutive options excluded from the calculation of diluted earnings per share were 31,048 and 36,178, respectively (three and six months ended June 30, 2022 – 29,600 and 27,094, respectively).

v3.23.2
Goodwill
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill

NOTE 4 – GOODWILL

The following table summarizes the goodwill movements in the year:

 

(in millions)

 

Gross Cost

 

Opening balance at January 1, 2023

 

$

358.8

 

Exchange effect

 

 

1.8

 

Closing balance at June 30, 2023

 

$

360.6

 

 

The exchange effect for the six months ended June 30, 2023 was $1.8 million relating to our Performance Chemicals segment and $0.0 million relating to our Fuel Specialties segment.

v3.23.2
Other Intangible Assets
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Other Intangible Assets

NOTE 5 – OTHER INTANGIBLE ASSETS

The following table analyzes other intangible assets movements in the year:

 

(in millions)

 

2023

 

Gross cost at January 1

 

$

291.1

 

Additions

 

$

6.7

 

Exchange effect

 

 

1.2

 

Gross cost at June 30

 

 

299.0

 

Accumulated amortization at January 1

 

 

(246.1

)

Amortization expense

 

 

(5.3

)

Exchange effect

 

 

(0.9

)

Accumulated amortization at June 30

 

 

(252.3

)

Net book amount at June 30

 

$

46.7

 

 

The amortization expense for the six months ended June 30, 2023 was $5.3 million (six months ended June 30, 2022 – $7.8 million).

 

In 2023, we capitalized $6.7 million in relation to our internally developed software for a new Enterprise Resource Planning (“ERP”) system covering our EMEA and ASPAC regions. The expenses capitalized include the acquisition costs for the software as well as the external and internal costs of the development.

v3.23.2
Pension and Post-Employment Benefits
6 Months Ended
Jun. 30, 2023
Retirement Benefits [Abstract]  
Pension and Post-Employment Benefits

NOTE 6 – PENSION AND POST EMPLOYMENT BENEFITS

The Company maintains a defined benefit pension plan covering certain current and former employees in the United Kingdom (the “UK Plan”). The UK Plan is closed to future service accrual and has a large number of deferred and current pensioners. The assets of the UK Plan are predominantly insurance policies, operating as investment assets, covering all liabilities. This reduces the UK Plan’s potential reliance on the Company for future cash funding requirements.

 

The Company also maintains an unfunded defined benefit pension plan covering certain current and former employees in Germany (the “German plan”). The German plan is closed to new entrants and has no assets.

 

The net periodic benefit of these plans is shown in the following table:

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

(in millions)

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Service cost

 

$

(0.9

)

 

$

(0.6

)

 

$

(1.8

)

 

$

(1.2

)

Interest cost on projected benefit obligation

 

 

(5.0

)

 

 

(2.6

)

 

 

(9.9

)

 

 

(5.4

)

Expected return on plan assets

 

 

6.3

 

 

 

4.2

 

 

 

12.5

 

 

 

8.5

 

Amortization of prior service cost

 

 

(0.1

)

 

 

(0.2

)

 

 

(0.2

)

 

 

(0.3

)

Amortization of actuarial net gains/(losses)

 

 

0.5

 

 

 

(0.2

)

 

 

1.0

 

 

 

(0.3

)

Net periodic benefit

 

$

0.8

 

 

$

0.6

 

 

$

1.6

 

 

$

1.3

 

 

The service cost has been recognized in selling, general and administrative expenses. All other items have been recognized within other income and expense. The amortization of prior service cost and actuarial net losses are a reclassification out of accumulated other comprehensive loss into other income and expense.

In addition, we have obligations for post-employment benefits in some of our other European businesses. As at June 30, 2023, we have recorded a liability of $4.0 million (December 31, 2022 – $4.1 million).

v3.23.2
Income Taxes
6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes

NOTE 7 – INCOME TAXES

A roll-forward of unrecognized tax benefits and associated accrued interest and penalties is as follows:

 

(in millions)

 

Unrecognized
Tax Benefits

 

 

Interest and
Penalties

 

 

Total

 

Opening balance at January 1, 2023

 

$

10.2

 

 

$

3.2

 

 

$

13.4

 

Net change for tax positions of prior periods

 

 

0.2

 

 

 

0.4

 

 

 

0.6

 

Closing balance at June 30, 2023

 

 

10.4

 

 

 

3.6

 

 

 

14.0

 

Current

 

 

 

 

 

 

 

 

 

Non-current

 

$

10.4

 

 

$

3.6

 

 

$

14.0

 

 

All of the $14.0 million of unrecognized tax benefits, interest and penalties would impact our effective tax rate if recognized.
 

In 2021 a non-U.S. subsidiary, Innospec Limited, entered into a review by the U.K. tax authorities under the U.K.’s Profit Diversion Compliance Facility (“PDCF”) in relation to the period 2017 to 2020 inclusive. The Company has determined that additional tax and interest totaling $1.1 million may arise as a result of the ongoing review. This includes an increase for foreign exchange movements of $0.1 million recorded in the six months to June 30, 2023.

A non-U.S. subsidiary, Innospec Performance Chemicals Italia Srl, is subject to an ongoing tax audit in relation to the period 2011 to 2014 inclusive. The Company has determined that additional tax, interest and penalties totaling $3.3 million may arise as a consequence of the tax audit. This includes an increase for foreign exchange movements of $0.1 million recorded in the six months to June 30, 2023. As any additional tax arising as a consequence of the tax audit would be reimbursed by the previous owner under the terms of the sale and purchase agreement, an indemnification asset of the same amount is recorded in the financial statements to reflect this arrangement.

In 2018 the Company recorded an unrecognized tax benefit in relation to a potential adjustment that could arise as a consequence of the Tax Cuts and Jobs Act of 2017 (“Tax Act”), but for which retrospective adjustment to the filed 2017 U.S. federal income tax returns was not permissible. The Company has determined that additional tax, interest and penalties totaling $9.6 million may arise in relation to this item. This includes an increase in interest accrued of $0.4 million in the six months to June 30, 2023.

Aside from certain tax returns that are closed after completion of an Internal Revenue Service ("IRS") audit, the Company and its U.S. subsidiaries remain open to examination by the IRS for certain elements of year 2017 and for years 2019 onwards under the statute of limitations. The Company’s subsidiaries in foreign tax jurisdictions are open to examination including Brazil (2018 onwards), Germany (2018 onwards), and the U.K. (2017 onwards).
 

v3.23.2
Long-Term Debt
6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
Long-Term Debt

NOTE 8 – LONG-TERM DEBT

As at June 30, 2023, and December 31, 2022, the Company had not drawn down on its revolving credit facility.

On May 31, 2023, Innospec Inc. and certain subsidiaries of the Company (together with the Company, the “Borrowers”) entered into a Multicurrency Revolving Facility Agreement with various lenders (the “Agreement”) which replaces the Company’s credit facility agreement dated September 26, 2019. The Agreement provides for a $250,000,000 four-year multicurrency revolving loan facility available to the Borrowers (the “Facility”). The Agreement also contains an accordion feature whereby the Company may elect to increase the total available borrowings by an aggregate amount of up to $125,000,000. The termination date of the Facility is May 30, 2027, but the Company has an option to request an extension of the Facility for a further year. As a consequence, the Company has capitalized $1.5 million of costs relating to the new Agreement which are to be amortized over the period to May 30, 2027. In addition the Company has written-off $0.5 million of capitalized costs relating to the previous agreement.

As at June 30, 2023, the deferred finance costs of $1.4 million (December 31, 2022 - $0.6 million) related to the arrangement of the credit facility, are included within other current and non-current assets at the balance sheet dates.

v3.23.2
Plant Closure Provisions
6 Months Ended
Jun. 30, 2023
Restructuring and Related Activities [Abstract]  
Plant Closure Provisions

NOTE 9 – PLANT CLOSURE PROVISIONS

The Company has continuing plans to remediate manufacturing facilities at sites around the world as and when those operations are expected to cease, or we are required to decommission the sites according to local laws and regulations. The liability for estimated plant closure costs includes costs for environmental remediation liabilities and asset retirement obligations.

The principal site giving rise to asset retirement obligations is the manufacturing site at Ellesmere Port in the United Kingdom. There are also asset retirement obligations and environmental remediation liabilities on a much smaller scale in respect of other manufacturing sites.

 

Movements in the provisions are summarized as follows:

 

(in millions)

 

2023

 

Total at January 1

 

$

57.2

 

Charge for the period

 

 

1.9

 

Utilized in the period

 

 

(2.4

)

Exchange effect

 

 

0.2

 

Total at June 30

 

 

56.9

 

Due within one year

 

 

(4.3

)

Due after one year

 

$

52.6

 

 

The charge for the six months ended June 30, 2023 was $1.9 million (six months ended June 30, 2022 – $1.9 million). The current year charge represents the accounting accretion only, with no changes for the expected cost and scope of future remediation activities. Amounts due within one year refer to provisions where expenditure is expected to arise within one year of the balance sheet date.

v3.23.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements

NOTE 10 – FAIR VALUE MEASUREMENTS

The following table presents the carrying amount and fair values of the Company’s financial assets and liabilities measured on a recurring basis:

 

 

June 30, 2023

 

 

December 31, 2022

 

(in millions)

 

Carrying
Amount

 

 

Fair
Value

 

 

Carrying
Amount

 

 

Fair
Value

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Non-derivatives:

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

165.9

 

 

$

165.9

 

 

$

147.1

 

 

$

147.1

 

Derivatives (Level 1 measurement):

 

 

 

 

 

 

 

 

 

 

 

 

Other current and non-current assets:

 

 

 

 

 

 

 

 

 

 

 

 

Emissions Trading Scheme credits

 

 

2.0

 

 

 

2.0

 

 

 

2.7

 

 

 

2.7

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives (Level 1 measurement):

 

 

 

 

 

 

 

 

 

 

 

 

Other current and non-current liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward exchange contracts

 

 

0.3

 

 

 

0.3

 

 

 

0.5

 

 

 

0.5

 

Non-financial liabilities (Level 3 measurement):

 

 

 

 

 

 

 

 

 

 

 

 

Other current and non-current liabilities: